| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.334 | 43.325 | 46.655 | 55.153 | 68.329 | 70.147 | 73.659 | 85.261 | 105.382 | 130.969 |
| Total Income - EUR | 39.437 | 43.326 | 49.809 | 55.175 | 68.338 | 72.219 | 73.662 | 85.265 | 105.387 | 130.976 |
| Total Expenses - EUR | 23.278 | 24.602 | 30.017 | 32.517 | 38.785 | 44.818 | 42.690 | 41.071 | 43.376 | 41.249 |
| Gross Profit/Loss - EUR | 16.158 | 18.725 | 19.792 | 22.658 | 29.553 | 27.402 | 30.972 | 44.194 | 62.011 | 89.727 |
| Net Profit/Loss - EUR | 14.975 | 18.291 | 18.660 | 22.106 | 28.870 | 26.700 | 30.250 | 43.341 | 60.978 | 85.876 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Amel-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.139 | 272 | 11.431 | 7.562 | 4.400 | 651 | 229 | 67 | 0 | 600 |
| Current Assets | 15.589 | 19.623 | 18.275 | 20.806 | 26.719 | 29.051 | 33.107 | 47.661 | 64.060 | 89.128 |
| Inventories | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 54 | 279 | 576 | 869 | 914 | 630 | 29.958 | 42.056 | 54.961 | 81.021 |
| Cash | 15.535 | 19.344 | 17.689 | 19.937 | 25.806 | 28.421 | 3.149 | 5.605 | 9.100 | 8.107 |
| Shareholders Funds | 15.029 | 18.345 | 18.713 | 22.158 | 28.920 | 26.749 | 30.282 | 43.372 | 61.009 | 85.924 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.699 | 1.550 | 10.993 | 6.211 | 2.199 | 2.953 | 3.054 | 4.355 | 3.051 | 3.804 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amel-Med Srl